Skip Nav Destination
Issues
1 September 2002
ISSN 1078-0432
EISSN 1557-3265
Editorial
Special Article
Advances in Brief
Clinical Trials
Increased Uptake of the Apoptosis-imaging Agent 99mTc Recombinant Human Annexin V in Human Tumors after One Course of Chemotherapy as a Predictor of Tumor Response and Patient Prognosis1
Tarik Belhocine; Neil Steinmetz; Roland Hustinx; Pierre Bartsch; Guy Jerusalem; Laurence Seidel; Pierre Rigo; Allan Green
Maintenance Biotherapy for Metastatic Melanoma with Interleukin-2 and Granulocyte Macrophage-Colony Stimulating Factor Improves Survival for Patients Responding to Induction Concurrent Biochemotherapy1
Steven J. O’Day; Peter D. Boasberg; Lawrence Piro; Timothy S. Kristedja; He-Jing Wang; Maureen Martin; Regina Deck; Patricia Ames; Kelly Shinn; Hannah Kim; Patricia Fournier; Guy Gammon
Regular Articles
Clinical Trials
A Phase I Study of Combined Modality 90Yttrium-CC49 Intraperitoneal Radioimmunotherapy for Ovarian Cancer1
Ronald D. Alvarez; Warner K. Huh; M. B. Khazaeli; Ruby F. Meredith; Edward E. Partridge; Larry C. Kilgore; William E. Grizzle; Sui Shen; J. Max Austin; Mack N. Barnes; Delicia Carey; Jeffrey Schlom; Albert F. LoBuglio
Postremission Therapy with Low-dose Interleukin 2 with or without Intermediate Pulse Dose Interleukin 2 Therapy Is Well Tolerated in Elderly Patients with Acute Myeloid Leukemia: Cancer and Leukemia Group B Study 94201
Sherif S. Farag; Stephen L. George; Edward J. Lee; Maria Baer; Richard K. Dodge; Brian Becknell; Todd Fehniger; Lewis R. Silverman; Jeffrey Crawford; Clara D. Bloomfield; Richard A. Larson; Charles A. Schiffer; Michael A. Caligiuri
Phase I Trial of 1α-Hydroxyvitamin D2 in Patients with Hormone Refractory Prostate Cancer1
Glenn Liu; Kurt Oettel; Gregory Ripple; Mary Jane Staab; Dorothea Horvath; Dona Alberti; Rhoda Arzoomanian; Rebecca Marnocha; Reginald Bruskewitz; Richard Mazess; Charles Bishop; Abhik Bhattacharya; Howard Bailey; George Wilding
Phase II Clinical Trial of N-(4-Hydroxyphenyl)retinamide and Tamoxifen Administration before Definitive Surgery for Breast Neoplasia1
S. Eva Singletary; Edward N. Atkinson; Ashraful Hoque; Nour Sneige; Ayse A. Sahin; Herbert A. Fritsche, Jr.; Reuben Lotan; Tao Lu; Walter N. Hittelman; Therese B. Bevers; Carol B. Stelling; Scott M. Lippman
Cancer Biology, Immunology, Cytokines
Research Articles
Molecular Oncology, Markers, Clinical Correlates
Experimental Therapeutics, Preclinical Pharmacology
Inter- and Intratumoral Disposition of Platinum in Solid Tumors after Administration of Cisplatin
William C. Zamboni; Anne C. Gervais; Merrill J. Egorin; Jan H. M. Schellens; Deborah R. Hamburger; Brian J. Delauter; Amy Grim; Eleanor G. Zuhowski; Erin Joseph; Dick Pluim; Douglas M. Potter; Julie L. Eiseman
Retraction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.